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Purpose: The main purpose of this study is to demonstrate the clinical implementa-
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tion of a comprehensive pencil beam scanning (PBS) daily quality assurance (QA)
program involving a number of novel QA devices including the Sphinx/Lynx/parallel‐
plate (PPC05) ion chamber and HexaCheck/multiple imaging modality isocentricity
(MIMI) imaging phantoms. Additionally, the study highlights the importance of testing the connectivity among oncology information system (OIS), beam delivery/imaging systems, and patient position system at a proton center with multi‐vendor
equipment and software.
Methods: For dosimetry, a daily QA plan with spot map of four different energies
(106, 145, 172, and 221 MeV) is delivered on the delivery system through the OIS.
The delivery assesses the dose output, ﬁeld homogeneity, beam coincidence, beam
energy, width, distal-fall-off (DFO), and spot characteristics — for example, position,
size, and skewness. As a part of mechanical and imaging QA, a treatment plan with
the MIMI phantom serving as the patient is transferred from OIS to imaging system.
The HexaCheck/MIMI phantoms are used to assess daily laser accuracy, imaging
isocenter accuracy, image registration accuracy, and six‐dimensional (6D) positional
correction accuracy for the kV imaging system and robotic couch.
Results: The daily QA results presented herein are based on 202 daily sets of measurements over a period of 10 months. Total time to perform daily QA tasks at our
center is under 30 min. The relative difference (Δrel) of daily measurements with
respect to baseline was within ± 1% for ﬁeld homogeneity, ±0.5 mm for range,
width and DFO, ±1 mm for spots positions, ±10% for in‐air spot sigma, ±0.5 spot
skewness, and ±1 mm for beam coincidence (except 1 case: Δrel = 1.3 mm). The
average Δrel in dose output was −0.2% (range: −1.1% to 1.5%). For 6D IGRT QA,
the average absolute difference (Δabs) was ≤0.6 ± 0.4 mm for translational and
≤0.5° for rotational shifts.
Conclusion: The use of novel QA devices such as the Sphinx in conjunction with
the Lynx, PPC05 ion chamber, HexaCheck/MIMI phantoms, and myQA software
was shown to provide a comprehensive and efﬁcient method for performing daily
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QA of a number of system parameters for a modern proton PBS‐dedicated treatment delivery unit.
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1 | INTRODUCTION

Lambert et al.5 evaluated the output, range, spot sigma, and position.
Since the DQA‐3 was originally designed for photon and electron

The number of proton therapy centers in the US continues to grow

daily QA, authors4,5 manufactured an in‐house phantom to use with

as there is an increasing interest in the use of protons to treat can-

the DQA‐3. Actis et al.6 published on PBS daily QA in 2017 utilizing

1

cer patients. Currently, proton centers employ different beam deliv-

an in‐house developed phantom that can accommodate multi‐leaf

ery techniques such as double scattering (DS), uniform scanning (US),

ionization chamber (MLIC). Actis et al.6 included beam characteristics

and/or pencil beam scanning (PBS). In the last few years, a number

(spot width, size, and position), range, and dose output for the dosi-

of existing proton centers have upgraded their beam delivery tech-

metric component of daily QA. Another PBS daily QA paper was

nique from DS/US to PBS. The majority of new proton centers is

published in 2017 by Bizzocchi et al.7 and investigated the use of

now conﬁgured with a more advanced PBS beam delivery technique

MatriXX‐PT (IBA Dosimetry, Schwarzenbruck, Germany) with an in‐

that has been shown to deliver a more conformal dose when com-

house phantom to evaluate range, spot size and position, and dose

pared to DS/US techniques.2 However, PBS proton beam delivery

output. In a more recent paper, Younkin et al.8 utilized the DQA‐3

has uncertainties associated with its spot size and spatial position.

along with an in‐house developed phantom to evaluate dose output,

Such demand for advanced PBS delivery warrants a comprehensive

beam range, and spot position as part of PBS daily QA.

understanding and monitoring of PBS beam characteristics. In addi-

The above‐mentioned studies4–8 demonstrate that investigators

tion to advances in proton beam delivery, image guidance used for

have used in‐house developed phantoms and software in conjunction

proton treatments has also evolved in recent years. In the past, the

with commercially available devices for PBS daily QA. Moreover, the

primary imaging modality in proton centers had been planar kV x‐ray

detectors used in previous PBS Daily QA studies4–8 were limited to

technique. Newer proton centers are incorporating imaging modali-

DQA‐3, MLIC, and MatriXX‐PT. Recently, a novel PBS dedicated com-

ties such as cone‐beam computed tomography (CBCT) and surface

mercial device Sphinx (IBA Dosimetry, Schwarzenbruck, Germany) has

imaging (SGRT). Due to the increase in delivery complexity of PBS

been made available to proton therapy centers. In order to be able to

and the use of multi‐modality image‐guidance systems for patient

quantify speciﬁc PBS beam characteristics, the Sphinx must be used in

treatments, there is a need to establish a comprehensive daily quality

conjunction with the Lynx (IBA Dosimetry, Schwarzenbruck, Germany)

assurance (QA) program that assesses safety, mechanical, dosimetric,

and a parallel‐plate (PPC05) ionization chamber (IBA Dosimetry, Sch-

and imaging parameters to ensure safe radiation delivery — similar

warzenbruck, Germany). Given the novelty of the device and no pub-

to the recommendations set forth by AAPM TG‐142 for photon‐

lished literature on the experience of the Sphinx and Lynx for PBS daily

based delivery systems. Additionally, certain proton centers may

QA, this work focuses on our clinical implementation and long‐term

employ multi‐vendor hardware and software for daily patient treat-

results when incorporating these devices for the dosimetric component

ment. For these centers, interconnectivity becomes a critical element

of our PBS daily QA. In addition to evaluating the dosimetric compo-

to assess and testing of data transfer among different softwares

nent of PBS proton beams, this work highlights the importance of a

(e.g., beam delivery, imaging, record, verify systems, etc.) should be

comprehensive daily QA program and addresses the need to develop

integrated as part of the daily QA program.

other components such as safety, mechanical, and imaging tests to

Several authors have published on proton daily QA using either

ensure safe radiotherapy treatment deliveries. Daily QA tests presented

commercial or in‐house developed devices.3–9 Arjomandy et al.3 pub-

in this work may serve beneﬁcial to proton centers looking to develop

lished a paper in 2009 providing an overview of QA procedures

and implement a comprehensive daily QA program based on recently

implemented at The University of Texas M. D. Anderson Proton

developed commercially available detectors and phantoms.

Therapy Center at Houston (PTC‐H). Arjomandy et al.3 veriﬁed the
output, distal range, and spread‐out Bragg Peak (SOBP) for daily QA
of DS proton beams using the solid‐water plastic. In 2012, Ding et

2 | MATERIALS AND METHODS

al.4 initially investigated the use of Sun Nuclear Daily‐QA 3 (DQA‐3)
device (Sun Nuclear Inc., Melbourne, FL, USA) for daily QA of US

Our proton center is structured as a multi‐vendor hardware and soft-

proton beams. In 2014, Lambert et al.5 extended the use of DQA‐3

ware platform environment. PBS proton plans are generated in

for daily QA of PBS proton beams. For PBS dosimetric tests,

RayStation (v.6.1.1.2; RaySearch Laboratories, Stockholm, Sweden),
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whereas ARIA (v.13.7; Varian Medical Systems, Palo Alto, CA) is
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the nozzle. The second x‐ray tube (orthogonal) is ﬁxed to one of the

used as the department record and verify system. IBA (Ion Beam

gantry structural beams. The x‐ray beam axis is perpendicular to the

Applications, Louvain‐la‐Neuve, Belgium) provides the ProteusPLUS

proton beam axis and to the gantry rotation axis. The orthogonal

PBS proton therapy system, which includes adaPT‐Deliver (v.11.0.3)

tube in conjunction with its ﬂat panel detector (SAD = 264.2 cm,

for beam delivery and adaPT‐Insight (v.2.1.0d) for imaging (kV‐kV x

SID = 317.1 cm, active pixel area = 43 cm × 43 cm, and active pixel

ray and kV‐CBCT). Additionally, the CatalystPT (C‐RAD, Uppsala,

resolution: 2874 × 2840 pixels) is used for the kV‐CBCT acquisition.

Sweden) system is used for surface imaging and gating applications.

In addition to the x ray based imaging system, the CatalystPT, a

The ﬂow chart of data transfer among the various software entities

three‐camera surface imaging system, is used to setup patients prior

is presented in Fig. 1.

to x ray based imaging, monitor patient position and posture during
treatment, and enable beam gating. The three cameras are posi-

2.A | Beam delivery system (BDS)

tioned to maximize ﬁeld coverage with the outer cameras being 43°
from the center camera.

A PBS proton beam is delivered using a PBS dedicated nozzle
(Fig. 2). As the proton beam enters the nozzle, an ionization chamber
1 (IC1) veriﬁes the alignment of the beam at the nozzle entrance. A

2.C | Record and verify system

set of two focusing quadrupole magnets focus the proton beam at

ARIA (v13.7) receives computed tomography (CT) images, DICOM

the isocenter. The proton beam is then scanned in Y direction by a

structure set, RT Plan, RT Dose, and DRR images from RayStation.

vertical scanning magnet followed by scanning in X direction with a

ARIA also receives the treatment record from adaPT Deliver and

horizontal scanning magnet. In order to direct the beam to a particu-

images (kV planar/CBCT images) from adaPT Insight.

lar location on a target, the beam position is steered using magnetic
ﬁelds. Ionization chambers 2 and 3 (IC2/3) monitor beam characteristics real‐time (beam size, position, and ﬂatness) and dose just before

2.D | Phantoms and detectors

the proton beam exists the nozzle. Snout holder allows the move-

The Sphinx phantom has a carbon frame with dimension of

ment of accessary drawer, which can include an optional range shif-

540 mm × 400 mm × 400 mm (Fig. 3). The carbon frame contains

ter (pre‐absorber) and snout. At our center, a range shifter of 7.5 cm

the markers for veriﬁcation of laser alignment. The phantom incorpo-

water equivalent thickness is used for clinical cases as necessary.

rates four wedges with various thicknesses for verifying the constancy of different proton beam energies (106, 145, 172, and

2.B | Imaging systems

221 MeV). The ﬁxed solid water block (RW3) and insert RW3 have
mass density of 1.045 g/cm3 and electron density of 3.386 × 1023/

The kV x‐ray imaging system includes two gantry mounted, x‐ray

cm3. The RW3 insert has dimensions of 35 mm width, 100 mm

tubes that rotate with the gantry. The ﬁrst x‐ray tube (portal) is

height, and variable length (250, 200, and 100 mm).

located in the PBS dedicated nozzle pre‐assembly, which is under

The four wedges are utilized to calculate the energy related

vacuum. The x‐ray tube is retracted from the beam line during the

parameters such as range, width, and distal-fall-off (DFO). The

proton beam irradiation. The ﬂat panel detector of portal (SAD =

energy calculation algorithm10 implemented within myQA software,

119.4 cm, SID = 177.0 cm, active pixel area = 28.2 cm × 40.6 cm,

version 2017‐002 (2.9.23.0) calculates the slight signal generated by

and active pixel resolution: 2232 × 3200 pixels) is located in front of

the radiation delivered over the RW3 wedge. The ﬁrst derivative of

F I G . 1 . Flow chart of data transfer
among RayStation, ARIA, adaPT‐Deliver
(beam delivery), and adaPT‐Insight
(imaging) in a ProteusPLUS pencil beam
scanning proton therapy system.
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F I G . 2 . Schematic representation of the beam delivery system equipment in the pencil beam scanning (PBS) treatment mode for an IBA
ProteusPLUS gantry‐based system. Note: The x‐ray tube (portal) is located in the PBS dedicated nozzle pre‐assembly, which is under vacuum.
The x‐ray tube is retracted from the beam line during proton beam irradiation.

(a)

(c)

(b)

(d)

F I G . 3 . (a) The Sphinx device is shown
with the ﬁducial insert for x‐ray vs proton
beam coincidence. (a‐c) The RW3 blocks
with wedges (W1, W2, W3, and W4) are
shown in frontal (a), back (b), and side (c)
views. The W1, W2, W3, and W4 are used
to measure the ranges, width, and distalfall-off of energies 106, 145, 172, and
221 MeV, respectively. (d) The RW3 block
is shown with the cutout for the PPC05
parallel plate chamber as well as the 3 cm
thickness buildup that is placed in front of
the chamber.

this rising part of signal is then calculated in order to identify the

in‐air measurement of spots at the level of the Lynx. The Lynx is a

physical edge of the corresponding RW3 block.10 The ﬁnal depth‐

gadolinium‐based scintillation detector (active surface area = 300

dose curve is calculated by assigning a value of depth to each pixel
of the image.10 The values of depths are extrapolated from data

mm × 300 mm) with a pixel resolution of 0.5 mm. A detailed
description of the Lynx is provided by Russo et al.13

interpolated with a cubic spline ﬁt.10 For better understanding on

For imaging quality assurance, the multiple imaging modality

the range calculation using wedge, readers are advised to refer to

isocentricity (MIMI) phantom along with the HexaCheck phantom

work published by Shen et al.11 and Deng et al.12

(Standard Imaging, Middleton, WI, USA) are used to perform daily,

The phantom also has an insert containing a pin with a ﬁducial at

six‐dimensional (6D) image‐guided radiation therapy (IGRT) QA of

its tip which is placed at the isocenter (Fig. 3). A dedicated RW3

the IBA adaPT‐Insight software and LEONI (LEONI Healthcare, Char-

insert (160 mm × 90 mm × 100 mm) contains a notch for a PPC05

tres France) robotic couch. The HexaCheck acts as a base for the

chamber for dose output constancy check. The PPC05 is covered

MIMI phantom and allows for the introduction of a ﬁxed 2.5°

with 3 cm thickness RW3 block so the chamber has a 3 cm build up

mechanical displacement in the yaw, pitch, and roll directions. For

(Fig. 3). The PPC05 chamber can then be connected to an electrom-

more information on the clinical use of MIMI and HexaCheck, read-

eter for dose output measurement. The phantom setup allows the

ers are advised to refer to white paper.14
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F I G . 4 . The spot map of a plan created
in RayStation for four different proton
beam energies (221, 172, 145, and
106 MeV) for the dosimetric testing of the
pencil beam scanning daily quality
assurance using the Sphinx and Lynx
devices is shown.

2.E | Workﬂow
Our current daily QA workﬂow includes two daily QA plans based
on two sets of devices: (a) Sphinx, Lynx, and PPC05 and (b) MIMI
and HexaCheck.

2.E.1 | Sphinx, Lynx, and PPC05
A daily QA plan was generated in RayStation (v.6.1.1.2) with spot
map of four different energies (Fig. 4). In order to mimic patient
treatment, a daily QA plan is delivered using adaPT‐Deliver on ProteusPLUS proton therapy system through ARIA. Dosimetry measurements are performed using a single couch top setup with the Sphinx,
Lynx, and PPC05 chamber (Fig. 5) For PBS daily QA dosimetric
quantiﬁcation, tests (Table 1) are categorized into: (a) spot position,
size, and skewness, (b) distal and proximal range, width, and DFO, (c)
radiation and imaging coincidence, (d) ﬁeld homogeneity, and (e)
dose output. For evaluation and analysis, myQA software (IBA
Dosimetry, Schwarzenbruck, Germany) was utilized for tests #a–d
and an in‐house excel sheet and DOSE2 electrometer (IBA Dosimetry, Schwarzenbruck, Germany) were used for test #e. Additionally,
veriﬁcation of patient positioning system (PPS) displacement and
lasers alignment is accomplished with the same setup. The workﬂow
using Sphinx, Lynx, and PPC05 is presented in Fig. 6. The total time

F I G . 5 . The daily couch top setup of the Sphinx, Lynx, and PPC05
for pencil beam scanning dosimetric testing of the daily quality
assurance procedure is shown. The gantry is set at 90° with the
robotic couch being set to 0°.

for this workﬂow is from 15 to 20 min without system interruptions.
placed in the HexaCheck and indexed to the couch top such that MIMI

2.E.2 | MIMI and HexaCheck

is aligned to the known translational and rotational offset shifts (Fig. 7)
Speciﬁcally, the known translational shifts were −13.4 mm in the lat-

A treatment plan with kV‐kV and CBCT setup ﬁelds was generated in

eral, −9.1 mm in the longitudinal, and 10.8 mm in the vertical direc-

RayStation using the CT images of the MIMI phantom. The plan treat-

tions, whereas the known rotational shifts were 2.2° for the pitch,

ment isocenter was deﬁned at the center of the MIMI. The MIMI is

−2.2° for the roll, and 3.5° for the yaw. First, a CBCT is acquired with
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T A B L E 1 Overview of daily quality assurance tests for a proton
pencil beam scanning delivery system.
Test items
Safety

Door interlock (beam off)
Audio/visual monitor(s)
Intercom

ΔðpÞ ¼ M(p) - B(p)

ET AL.

(1)

where, p = translational (e.g., lateral) or rotational parameter (e.g.,
yaw); M(p) = daily measured value of parameter, p; B(p) = baseline
value of parameter, p; Δ(p) = difference between measured and
baseline values of parameter, p.

Beam on indicator
Alarm indicator

3 | RESULTS

X‐ray on indicator

Mechanical,
imaging, and
OIS connectivity

Room radiation monitor

The daily QA results presented herein are based on a set of 202 daily

Room search/clear button

measurements over the period of 10 months on an IBA gantry‐based

Beam pause

ProteusPLUS PBS proton therapy system. The analysis of results was

Beam stop

carried out in two steps. First, the relative difference (Δ) was calcu-

Beam delivery controller reset

lated by comparing daily (D) measurements against baseline (B) mea-

Collisional interlocks

surements. Second, a statistical process control (SPC) analysis was

Laser localization

performed to assess the temporal stability of each parameter and

Imaging and treatment coordinate
coincidence

tistical control. The QI Macros (KnowWare International, Denver, CO)

Positioning/repositioning
(translational & rotational)

add‐on statistical analysis package (v.2018) for Microsoft Excel was

Gantry angle

ated parameter, the upper control limit (UCL), lower control limit (LCL),

Range shifter detection

and average values were calculated using a XbarR control chart in QI

Dual source kV‐kV x‐ray image acquisition

Macros. An example of the control chart for the dose output of the

CBCT acquisition

172 MeV beam as well as the distal range (R80) of the 221 MeV beam

Connectivity between OIS and
delivery unit software

Dosimetry

determine whether the various parameters of the system were in sta-

used for the statistical analysis. Speciﬁcally, for the Δ of each evalu-

is displayed in Fig. 9. The UCL and LCL are deﬁned by +3σ and −3σ,
respectively, from the average value. The 3σ means 99.73% of the val-

X‐ray vs surface imaging isocenter
coincidence

ues lie within three standard deviations of the mean.

Spot position

3.A | Dose output and ﬁeld homogeneity

Spot sigma
Spot skewness

Dose output and ﬁeld homogeneity were evaluated for energies of

Distal range

172 and 221 MeV, respectively. Table 2 and Fig. 10 show that the

Proximal range

average Δ in dose output was −0.2% (range, −1.1%–1.5%) relative

Width
Distal-fall-off (DFO)

to baseline, and the Δ in ﬁeld homogeneity was within ±1% (range,
−1.0%–0.7%). The 3σ of the dose output and ﬁeld homogeneity
were ±0.7% and ±0.3%, respectively (Table 2).

Imaging vs proton beam isocenter
coincidence
Field homogeneity
Dose output

3.B | Energy, width, and DFO
The energy, width, and DFO were evaluated for 106, 145, 172, and
221 MeV energies. Table 2 shows the Δ in distal and proximal
ranges (R80) were within ±0.5 mm for all four energies. For both the

gantry rotation from 270° to 90°, and the acquired CBCT images are

distal and proximal ranges, the 3σ (Table 2) of all four energies was

registered to the reference CT images of the MIMI in adaPT‐Insight to

±0.3 mm. For both the width and DFO, the Δ was within ±0.4 mm.

obtain the 6D correction vector. The difference between the daily cor-

The 3σ (Table 2) of width for all four energies was ±0.2 mm,

rection vectors (translational and rotational) and baseline values are

whereas the 3σ of DFO was ±0.1 mm for energies 145, 172, and

calculated using Eq. (1) provided below. After applying correction vec-

221 MeV and 0 mm for 106 MeV.

tor to the PPS, kV‐kV x‐ray imaging is performed to verify the ﬁnal
position of the MIMI phantom is accurate. Both the kV‐kV x‐ray and
CBCT images are transferred to ARIA for ofﬂine review. The workﬂow

3.C | Spots characteristics

using MIMI and HexaCheck is presented in Fig. 8. The total time for

Spots characteristics (position, size, and skewness) were evaluated

this workﬂow is about 10 min.

for four spots (106, 145, 172, and 221 MeV). Table 3 and Figs. 11
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F I G . 6 . The workﬂow for the dosimetric component of the daily quality assurance of a pencil beam scanning treatment unit using the
Sphinx, Lynx, and PPC05 is shown.

and 12 show that the Δ in spots positions (X & Y) was within
±1 mm, and the Δ in in‐air spot sigma (X & Y) was within ±10% for
all four spots. The 3σ (Table 3) evaluation of spot position showed
that all four spots had slightly lower value in y direction (±0.4 mm)
compared to the one in x direction (±0.6). For the in‐air spot sigma,
the 3σ was found to increase with beam energy, and it increased
from ±0.9% to ±2.1% for in‐air spot sigma X and from ±1.1% to
±3.6% for in‐air spot sigma Y. The Δ in spots skewness (X & Y) was
within ±0.5 for all four spots (Table 3). The 3σ of spot skewness ranged from ±0.2 to ±0.3 (Table 3).

3.D | X‐ray vs proton beam coincidence
Table 2 and Fig. 13 show that the Δ in x‐ray and proton beam coincidence (X and Y directions) was within ±1 mm except in one case
(Δ = 1.3 mm). The 3σ of beam coincidence was ±0.7 mm in X and
±0.5 mm in Y directions (Table 2).

3.E | Translational and rotational shifts
Figure 14 shows the Δ in translational and rotational shifts from
the baseline values. The Δ ranged from −1.0 to 2.3 mm in lateral, from −1.8 to 0.9 mm in longitudinal, and from −1.8 to
1.3 mm in vertical directions. For rotational shifts, the Δ ranged
from −0.8° to 0.9° for pitch, from −0.6° to 1.4° for roll, and
from −0.7° to 0.8° for yaw. The 3σ of the translational shifts
F I G . 7 . The couch top setup of the MIMI and HexaCheck
phantoms at the predeﬁned position of the LEONI six‐dimensional
robotic couch. The MIMI phantom is positioned with both
translational and rotational offsets applied as shown above.

was slightly higher in lateral (±0.8 mm) than in longitudinal
(±0.6 mm) and vertical (±0.6 mm) directions, whereas for the
rotational shifts, the 3σ was ±0.2° for yaw and ±0.3° for pitch
and roll (Table 4).
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F I G . 8 . The workﬂow for the imaging component of the daily quality assurance of a pencil beam scanning treatment unit using the MIMI
and HexaCheck is illustrated.

4 | DISCUSSION

Conceptionally, in attempting to establish tolerances for speciﬁc
tests of a quality assurance program, a number of strategies may

The daily QA program discussed in this work was designed with

be employed to determine the tolerance action value. One such

a few concepts in mind, namely: (a) establish a comprehensive

approach is to follow the recommended tolerances established by

QA program incorporating proposed recommendations from forth-

published guidelines that were conceived by the consensus of a

coming TG‐224,9 (b) mimic the typical patient treatment work-

group of experienced users — that is, for example, an AAPM task

ﬂow to validate data transfer, and (c) utilize novel commercial

group report. A second could be to evaluate the impact on the

devices to facilitate comprehensive and efﬁcient testing. Due to

patient dose distribution due to variations in that speciﬁc parame-

the unique software infrastructure at our center, daily proton

ter. For example, there have been publications characterizing the

therapy treatments are delivered using multivendor hardware and

impact of spot size on treatment plan quality.15 A third approach is

associated software. Because of potential risks of connectivity

to use statistical process control to evaluate whether speciﬁc

issues, testing connectivity among the OIS and beam delivery/

parameters are behaving in a stable and controlled manner.16,17

imaging systems on a daily basis helps validate the workﬂow

With this information, it is possible to use statistical methods to

functionality and can potentially detect issues prior to patient

determine the system speciﬁc action level tolerances due to the

treatments. In developing a daily QA program for a PBS proton

system performance. In using statistical process control, the

therapy system, there is currently limited guidance regarding the

methodology is to ﬁrst establish a process of testing a parameter,

speciﬁc tests, frequency of testing, and tolerances for each test.

test and observe, and characterize the behavior of the speciﬁc

Part of the challenge with standardized guidance stems from the

parameter — for example, dose output, spot size, spot position,

variability in delivery technologies (e.g., gantry, ﬁxed‐beam, etc.),

etc. — over a time period. By characterizing the behavior, it is pos-

techniques (e.g., double scatter, uniform scanning, etc.) as well as

sible to determine when a parameter is out of control and is statis-

different IGRT imaging techniques (e.g., kV‐kV, CBCT, CT‐on‐rails,

tically an outlier. This helps provide guidance as to when to act. In

etc.). Currently, there is an AAPM TG‐224 working on a report

this study, 10 months’ worth of data was collected to characterize

to address these issues and provide recommendations; however,

the behavior of our proton PBS delivery system. Our goal was to

as of date, there is no ofﬁcial publication. There is, however, a

measure the stability of multiple parameters and establish toler-

growing consensus as to a limited set of tests and their accepted

ances based on our speciﬁc system performance and not on gen-

4–9

Although, it is important

eric guidelines. With the assumption that a parameter value is

to mention that the determination of action level tolerances still

approximately distributed normally, control limits based purely on

remains a challenge.

the behavior of the variability can be generated. Using control

frequency from recent publications.
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F I G . 9 . The XbarR control charts for the dose output and distal range (R80) are shown. Statistical process control methods were used to
determine the stability of the beam parameters. Upper control limit (UCL) = +3σ and lower control limit (LCL) = −3σ were used to determine if
individual measurements required action.

charts, a delivery system‐speciﬁc action level (3σ) table can be
determined for daily QA.

Looking at proton beam characteristics such as in‐air spot size,
Lambert et al.5 and Bizzochi et al.7 evaluated in‐air spot size of a sin-

With regards to dose output, the AAPM TG 14218 recommends

gle energy with tolerances of ±10% and ±15%, respectively. How-

the tolerance of 3% for photon and electron, whereas Lambert et

ever, if the institution evaluates multiple spots of different energies

al.5 and Actis et al.6 have used a tolerance of 2% and Younkin et al.8

on a daily basis, a single tighter tolerance value for all energies may

used tolerance of 1% for PBS protons. In our current daily QA setup,

not be ideal. For spots characteristics, we deliver four spots of dif-

dose output is typically measured by taking at least two readings

ferent energies (106, 145, 172, and 221 MeV) and myQA software

with a PPC05 chamber. The statistical process control analysis

is used to analyze the in‐air spot size (sigma). For a spot of

results from the past 10 months show that the 3σ of dose output is

221 MeV, our daily measured in‐air spot sigma deviated from the

±0.7%, which is a tighter tolerance compared to the published litera-

baseline value by up to ±9.5%, whereas for the lower energy spots

4–6,8,9

For proton range and energy, authors have used different

(106 and 145 MeV), the deviation of daily in‐air spot sigma from

tolerances of 0.5 mm,8 1 mm,4,5 and 2 mm.6,7,9 For our 10‐month

baseline value was <±5%. The 3σ of in‐air spot size also showed a

data, we noticed the variation in range (R80) within ±0.5 mm for all

similar trend such that there is an increase in deviation with energy.

four energies evaluated (106, 145, 172, and 221 MeV). The 3σ of

Additionally, there can be difference in X and Y directions of in‐air

daily range tolerance of ±0.3 mm is reasonable on ProteusPLUS PBS

spot size, especially at higher energies, on an IBA ProteusPLUS pro-

proton machine if the institution uses the Sphinx and myQA soft-

ton therapy system. For spot position tolerance, there is no common

ware for daily range veriﬁcation.

agreement among investigators. For instance, spot position tolerance

ture.
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T A B L E 2 Results of dose output, ﬁeld homogeneity, range, width, distal-fall-off (DFO), and x‐ray vs proton beam coincidence based on daily
QA measurements (n = 202).
SPC
Energy (MeV)

Avg.

Range

3σ

UCL

LCL

Dose output (%)

E172

−0.2

−1.1–1.5

±0.7

0.5

−0.8

Field homogeneity (%)

E221

0.0

−1.0–0.7

±0.5

0.5

−0.6

R80‐distal range (mm)

E106

−0.1

−0.3–0.1

±0.3

0.2

−0.3

E145

−0.2

−0.3–0.1

±0.3

0.1

−0.4

R80‐proximal range (mm)

Width (mm)

Distal-fall-off (mm)

E172

0.2

0.0–0.5

±0.3

0.5

−0.1

E221

−0.2

−0.5–0.3

±0.3

0.2

−0.5

E106

−0.1

−0.3–0.1

±0.3

0.2

−0.4

E145

−0.2

−0.4–0.1

±0.3

0.1

−0.5

E172

0.1

−0.3–0.4

±0.3

0.4

−0.3

E221

−0.2

−0.5–0.5

±0.3

0.1

−0.6

E106

0.0

0.0–0.1

±0.2

0.2

−0.1

E145

0.0

−0.1–0.2

±0.2

0.2

−0.1

E172

0.2

0.0–0.4

±0.2

0.4

−0.1

E221

0.0

−0.2–0.3

±0.2

0.2

−0.2

E106

0.0

−0.1–0.1

0

0.0

0.0

E145

0.0

0.0–0.1

±0.1

0.2

−0.1

E172

0.0

0.0 – 0.1

±0.1

0.1

0.0

E221

0.0

−0.1–0.1

±0.1

0.1

−0.1

Beam coincidence‐X (mm)

E106

0.4

−0.8–1.3

±0.7

1.1

−0.4

Beam coincidence‐Y (mm)

E106

0.1

−0.7–0.9

±0.5

0.6

−0.4

A relative difference (Δ) was calculated by comparing daily (D) measurements against baseline (B) measurements. Upper control limit (UCL) and lower
control limit (LCL) are based on statics process control (SPC) charts. UCL = +3σ and LCL = ‐3σ are from the average value.

F I G . 1 0 . (Left) Daily dose output for 172 MeV pencil beam scanning (PBS) proton beam;(Right) Daily ﬁeld homogeneity for 221 MeV PBS
proton beam. [The relative difference (Δ) was calculated by comparing daily (D) measurements (n = 202) against baseline (B) measurement.]
of ±1 mm from Bizzochi et al.7 is more stringent than ±1.5 mm sug5

8

reduce the uncertainties introduced by the user setup and robotic

gested by Lambert et al. and Younkin et al. and ±2 mm applied by

couch. For our current daily QA protocol and workﬂow (Fig. 6), a

Actis et al.6 Although our daily spot positions (a total of four spots

tighter spot position tolerance of ±0.6 mm is feasible.

with energies 106, 145, 172, and 221 MeV) varied from baselines

For x‐ray and proton beam coincidence, we currently use a single

values by up to ±0.9 mm on certain days, the 3σ of spot positions

spot of energy 106 MeV. Based on 10 months results, the deviation

was lower (±0.6 mm in X and ±0.4 mm in Y). Since the Sphinx and

in coincidence was found to be within ±1.5 mm, which was used as

Lynx are indexed on the couch top, the accuracy of robotic couch

the tolerance by Lambert et al.5 The 3σ of beam coincidence (x ray

could also potentially affect the spot positions results. Hence, the

and proton) was found to be ±0.7 mm in X and ±0.5 mm in Y direc-

veriﬁcation of daily QA setup with planar kV x rays is essential to

tions. As shown in Fig. 6, we use the setup ﬁeld to drive the 6D
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T A B L E 3 Results of spots characteristics (position, sigma, and skewness) based on daily quality assurance measurements (n = 202).
SPC
Avg.

Range

3σ

UCL

LCL

Spot position‐X (mm)
Spot1 (E106)

0.0

−0.8–0.8

±0.6

0.6

−0.6

Spot2 (E145)

−0.1

−0.9–0.7

±0.6

0.5

−0.7

Spot3 (E172)

−0.1

−0.9–0.7

±0.6

0.6

−0.7

Spot4 (E221)

0.3

−0.5–0.9

±0.6

0.9

−0.3

Spot1 (E106)

0.3

−0.3–0.9

±0.4

0.7

−0.1

Spot2 (E145)

0.2

−0.3–0.7

±0.4

0.6

−0.2

Spot3 (E172)

0.3

−0.3–0.8

±0.4

0.7

−0.1

Spot4 (E221)

0.3

−0.4–0.9

±0.4

0.7

0.0

Spot1 (E106)

−0.3

−1.8–0.0

±0.9

0.6

−1.2

Spot2 (E145)

0.8

−4.8–2.4

±1.7

2.5

−1.1

Spot3 (E172)

1.3

−2.7–2.7

±1.9

3.2

−0.4

Spot4 (E221)

−3.8

−6.5–0.0

±2.1

−1.7

−5.9

Spot1 (E106)

0.0

−1.8–3.6

±1.1

1.1

−1.1

Spot2 (E145)

0.6

−4.8–4.8

±2.0

2.6

−1.4

Spot3 (E172)

−1.9

−7.9–5.3

±2.7

0.9

−4.5

Spot4 (E221)

−0.7

−9.4–9.4

±3.6

2.8

−4.3

Spot1 (E106)

0.1

−0.1–0.2

±0.2

0.3

−0.2

Spot2 (E145)

0.1

−0.1–0.3

±0.3

0.3

−0.2

Spot3 (E172)

0.0

−0.3–0.3

±0.3

0.3

−0.3

Spot4 (E221)

0.0

−0.3–0.3

±0.3

0.3

−0.3

0.0

−0.2–0.2

±0.2

0.2

−0.2

Spot2 (E145)

0.2

−0.1–0.5

±0.2

0.4

−0.1

Spot3 (E172)

−0.2

−0.4–0.0

±0.3

0.1

−0.5

Spot4 (E221)

0.0

−0.2–0.3

±0.3

0.3

−0.3

Spot position‐Y (mm)

Spot sigma‐X (%)

Spot sigma‐Y (%)

Spot skewness‐X

Spot skewness‐Y
Spot1 (E106)

A relative difference (Δ) was calculated by comparing daily (D) measurements (n = 202) against baseline (B) measurements. Upper control limit (UCL) and
lower control limit (LCL) are based on statics process control (SPC) charts. UCL = +3σ and LCL = −3σ are from the average value.

robotic couch to its predeﬁned position such that the ﬁducial (2 mm

the use of Sphinx and Lynx for daily imaging QA would be more

in diameter) that is a part of our indexed couch top setup is at the

effective in reducing total daily QA time in the treatment room,

imaging isocenter. Once the portal kV‐kV x‐ray image of the setup is

we noticed that the CBCT acquisition and automatic image regis-

acquired, the center of cross‐hair (imaging isocenter) is projected at

tration in adaPT Insight for Sphinx and Lynx is not optimal. Hence,

the center of ﬁducial manually. It was found that the combination of

the MIMI phantom in conjunction with the HexaCheck is used to

accuracy of robotic couch, phantom setup, and manual alignment of

assess the 6D correction vector, which is calculated based on the

cross hair at the center of ﬁducial could affect the localization of the

automatic rigid registration of the acquired CBCT images to the

ﬁducial at the imaging isocenter. Hence, the robust indexing of

reference CT images of the MIMI Phantom. Lambert et al.5 and

the phantom along with well‐deﬁned manual alignment process of

Younkin et al.8 have provided ±1 mm as the tolerance of couch

the ﬁducial with imaging isocenter is critical in determining the coin-

correction vector. Both of these publications5,8 utilized the kV‐kV

cidence of x‐ray and proton beam.

x‐ray imaging of the DQA‐3 device to calculate the correction vec-

In our current patient treatment workﬂow, we typically acquire

tor for translational shifts only, whereas we have utilized the CBCT

CBCT images followed by orthogonal kV‐kV x‐ray images. Although

of the MIMI/HexaCheck to assess the 6D correction vector, which
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F I G . 1 1 . The difference (mm) in positions X and Y of spot1 (106 MeV), spot2 (145 MeV), spot3 (172 MeV), and spot4 (221 MeV). [The
relative difference (Δ) was calculated by comparing daily (D) measurements (n = 202) against baseline (B) measurement.]

includes both the translational and rotational shifts. Based on 202

region of interest (ROI) for image registration in adaPT Insight, and

sets of measurements, the 3σ of translational shifts (lateral, longitu-

(d) image registration algorithm implemented within adaPT Insight

dinal, and vertical) ranged from ±0.6 to ±0.8 mm, and the 3σ of

imaging system.

rotational shifts (pitch, roll, and yaw) ranged from ±0.2° to ±0.3°.

In addition to planar kV x rays and CBCT, QA on the C‐RAD Cat-

The variation in daily 6D correction vector in our current daily QA

alystHD surface imaging is performed daily by utilizing a vendor sup-

setup is found to be mainly due to the combination of (a) repro-

plied

ducibility of MIMI/HexaCheck setup on the couch top, (b) accuracy

recommendations, the functionality of the CatalystHD system and

of 6D LEONI robotic couch, (c) user dependency on selection of

coincidence of the surface imaging and laser isocenter is veriﬁed.

daily

QA

phantom.

Following

the

TG‐147

daily

QA
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F I G . 1 2 . The difference (%) in Sigma X and Y of spot1 (106 MeV), spot2 (145 MeV), spot3 (172 MeV), and spot4 (221 MeV). [The relative
difference (Δ) was calculated by comparing daily (D) measurements (n = 202) against baseline (B) measurement.]
Speciﬁcally, the C‐RAD daily QA phantom is aligned to the room

Lastly, for many proton centers, efﬁciency is an important ele-

isocenter using the room/gantry lasers. Once positioned, the daily

ment being that beam access is limited. Recently, published literature

QA phantom is imaged, and the agreement between the laser

have reported proton daily QA time of 10 min,8 20 min,7 and

isocenter and surface imaging isocenter is quantiﬁed. Tolerances and

30 min.5,6 At our center, the daily QA time is under 30 min, which

19

Our cur-

also includes the workﬂows presented in Fig. 6 and 8. The variation

rent surface imaging daily QA tests include the laser accuracy, func-

of daily QA time among different studies is mainly due to an incon-

tionality of the system, and calculation of translational shifts

sistency in the number and type of daily QA tests being performed

(tolerance ±1 mm).

at different institutions. For example, the coincidence of x‐ray and

stability have been previously reported by Stanley et al.
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X‐ray vs proton beam coincidence in x and y directions. A single spot of 106 MeV was used for the coincidence.

F I G . 1 4 . Difference between translational/rotational correction vectors and known offset (baseline) values for subsequent kV‐cone‐beam
computed tomography imaging daily quality assurance measurements (n = 202).
proton beam is tested by Lambert et al.5 only, and in‐air spot size is
5

6

7

reported by Lambert et al., Actis et al., and Bizzochi et al. Further4–8

unavailability of CBCT in the treatment room or difference in daily
QA policies at the authors’ institutions.4–8 The inclusion of CBCT in

reported the CBCT acquisition and its

our daily QA workﬂow (Fig. 8) has certainly contributed about 5 min

functionality as a part of daily QA. This could be due to

toward the total daily QA time at our center. In addition of

more, none of the studies
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T A B L E 4 Comparison of 3σ values based on 202 sets of measurements with tolerance threshold from published literature.
Daily QA tests

3σ based on control charts

Threshold from published literature

Dose output

±0.7%

±1%8, ±2%5,6,9, ±3%4

Field homogeneity

±0.5%

±2%9

Distal range

±0.3 mm

±0.5 mm8, ±1 mm4,5, ±2 mm6,7,9

Proximal range

±0.3 mm

±2 mm9

Width

±0.2 mm

Not available

0 mm for E106

Not available

Distal-fall-off (mm)

±0.1 mm for E145, E172 & E221
Beam coincidence X

±0.7 mm

Beam coincidence Y

±0.5 mm

Spot position X

±0.6 mm

Spot position Y

±0.4 mm

In‐air spot sigma X

±0.9% for E106

±1.5 mm5, ±2 mm9

±1 mm7, ±1.5 mm5,8, ±2 mm6,9

±10%5,9, ±15%7

±1.7% for E145
±1.9% for E172
±2.1% for E221
In‐air spot sigma Y

±1.1% for E106
±2.0% for E145
±2.7% for E172
±3.6% for E221

Skewness X

±0.2 for E106

Not available

±0.3 for E145, E172 & E221
Skewness Y

±0.2 for E106 & E145
±0.3 for E172 & E221

PPS translational

±1 mm4,5,8,9

±0.8 mm for lateral (X)
±0.6 mm for longitudinal (Y) and vertical (Z)

PPS rotational

±0.3° for pitch and roll

Not available

±0.2° for yaw

calculating the 6D correction vectors by using CBCT, this test allows

efﬁcient tool to perform daily, 6D IGRT QA of the IBA adaPT Insight

us to test the functionality of x‐ray tube, collision detection soft-

software and LEONI robotic couch.

ware, and adaPT Insight as well as transfer of CBCT images to the
OIS for ofﬂine review.
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ous aspects of our delivery system which include PBS beam parameters and imaging/couch accuracy. Our daily QA results from over
10 months demonstrate consistent beam stability of the ProteusPLUS
PBS proton therapy system. If CBCT is available, it is recommended to
test its functionality on a daily basis mimicking a patient treatment
scenario. The use of MIMI/HexaCheck can serve an accurate and
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